Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study academic.oup.com Submitted by burtzev t3_10vg0r8 on February 6, 2023 at 7:44 PM in science 22 comments 53
[deleted] t1_j7ki4tq wrote on February 7, 2023 at 1:36 PM Reply to comment by _MonteCristo_ in Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study by burtzev [removed] Permalink Parent 1
Viewing a single comment thread. View all comments